Labiotech.eu

News and Trends 22 Jun 2015

American Companies are Invading London’s Biotech Stock Market

[Update: On June 19, Puretech successfully raised $171M – approximately €150M – during its IPO, setting its market cap at €509M] Boston-based PureTech Health plans to raise €147M on the London stock market, following the path of Verseon, a San Diego-based bioinformatic company that raised €92M earlier this month. Is there a new American trend to earn cash in […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Jun 2015

Biotech to Revolutionize the Millennial Production of Carmine!

The Danish company Chr Hansen, through a partnership with the University of Copenhagen, created a process able to produce carmine dye by fermentation. Thanks to this discovery, the company is disrupting a millennial production method and stepping up to the plate, becoming a real game changer. With its particular deep-red color, carmine is one of the most […]

June 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 19 Jun 2015

BIO2015: Over and Out!

Three is the magic number as they say… After bringing you the highlights of the first and second day of the biggest Biotech Convention worldwide, we couldn’t give up on you so close from the end. So without further ado, here’s the summary of day three. Katrine Bosley, CEO of Editas, hosted Arnt Schottelius from MorphoSys, Loredana Ablondi, […]

June 19, 2015 - 3 minutesmins - By Alexandre Lowrey

News and Trends 19 Jun 2015

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

[UPDATE 19/06/2015]: Yesterday, Celyad launched its IPO on NASDAQ and the closing is expected to occur on 24 June 2015. Celyad, formely known as Cardio3, is preparing to cross the Atlantic to launch an IPO on NASDAQ. The company, which is already listed on Euronext Paris and Euronext Brussels, aims to raise €103.2M ($115 million) on […]

June 19, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 19 Jun 2015

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

Servier is fattening up its oncology assests with the acquisition of Taiho Pharmaceutical’s treatment of refractory mestatic colorectal cancer. The French laboratories will commercialize the molecule in Europe and other countries. Taiho Pharmaceutical and Servier come to an agreement for the development and commercialization of TAS-102 in Europe. The drug is an oral combination anticancer drug […]

June 19, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 18 Jun 2015

BIO2015: The Marathon Keeps On Going!

Yesterday, we covered the launch of the biggest Biotech event worldwide, currently taking place in Philadelphia. And you guessed it, we’re not going to leave you in the dark of this incredible convention, so get comfy and catch up with a few of the highlights of the second day. Wednesday started off with an interesting […]

June 18, 2015 - 3 minutesmins - By Alexandre Lowrey

News and Trends 18 Jun 2015

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its US presence and benefit from Boston’s leading position in the gene therapy field. Gene Therapy is the next big thing in Biotech and is now moving from a theoretical dream to reality. Boston is clearly the hotspot for […]

June 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Jun 2015

Innovate UK accelerates Sareum’s fight against Leukemia

Innovate UK, the country’s innovation agency, keeps promoting technology in the British islands. The latest beneficiary is Sareum, a cancer specialist biotech with a strong autoimmune disease programme. The company received €195.5k to fight an early-age type of leukaemia. T-Cell Acute Lymphoblastic Leukaemia is a rare type of leukaemia that most often occurs in late […]

June 17, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 17 Jun 2015

Deinove to challenge the Carotenoid Business

Carotenoids are powerfull antioxidants and essential in the production of vitamin A. The French synthetic biology biotech Deinove signed an agreement with the Canadian company POS Bio-Sciences with the hope of initiating a major breakthrough to the carotenoid market. Produced by all green plants, algae, some fungi and cyanobacteria, carotenoid is a group of more than 600 known […]

June 17, 2015 - 3 minutesmins - By Joachim Eeckhout

eye Bayer Healthcare Johns Hopkins University

News and Trends 16 Jun 2015

Bayer set a strategic alliance with J. Hopkins in retinal diseases

Bayer HealthCare and the Johns Hopkins University in Baltimore have entered into a five-year collaboration to develop ophthalmic therapies. The partners will jointly work on the discovery of treatments of retinal diseases such as age-related macular degeneration. The goal of the strategic research alliance is to accelerate the translation of innovative approaches from the laboratory […]

June 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Jun 2015

Novartis Uses Antibodies from Cured Patients to Fight Viruses

Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase II clinical trial. This monoclonal antibody was developed thanks to Humabs’ technology platform using antibodies from cured patients. Back in 2009, Humabs and Novartis entered into an exclusive licensing agreement for the use of selective human monoclonal antibodies discovered by […]

June 16, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 15 Jun 2015

GSK’s undercover incubator baked three new Biotechs

The partnership between GlaxoSmithKline and Avalon Ventures launched three early-stage life science companies. Adrenergics, CadheRx Therapeutics and Calporta Therapeutics will each receive up to €8.9M in a Series A financing, aside from support from their two godfathers. Three new companies were launched today as a result of Avalon’s fruitful collaboration with GSK. The partnership, which […]

June 15, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

American Companies are Invading London’s Biotech Stock Market

Biotech to Revolutionize the Millennial Production of Carmine!

BIO2015: Over and Out!

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

BIO2015: The Marathon Keeps On Going!

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

Innovate UK accelerates Sareum’s fight against Leukemia

Deinove to challenge the Carotenoid Business

Bayer set a strategic alliance with J. Hopkins in retinal diseases

Novartis Uses Antibodies from Cured Patients to Fight Viruses

GSK’s undercover incubator baked three new Biotechs

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!